Search - tctmd.com

Displaying 241 - 260 of 1206

Sort: Relevancy | Date

FDA Says Newer Paclitaxel Data Is ‘Comforting’ but Limited

News Daily News

FDA Says Newer Paclitaxel Data Are ‘Comforting’ but Limited

L.A. McKeown

January 12, 2021

News Daily News

Stable CAD With High-Risk Anatomy Warrants PCI or CABG, APPROACH Suggests

Michael O'Riordan

January 05, 2021

News Industry News

Efemoral Medical Announces Successful First-In-Human Use of The Efemoral™ Vascular Scaffold System

December 14, 2020

News Conference News VIVA 2020

DISRUPT PAD III: Lithotripsy Shows Promise in Heavily Calcified PAD

L.A. McKeown

November 09, 2020

News Conference News TCT 2020

EXAMINATION Surprise: Few Late Event Gaps Between DES and BMS in STEMI

L.A. McKeown

October 22, 2020

Direct Temsirolimus Delivery Shows Promise in BTK: Phase II Study

News Conference News TCT 2020

Direct Temsirolimus Delivery Promising in BTK: TANGO Phase II Study

Caitlin E. Cox

October 18, 2020

Presentation TCT 2020

In-Stent-Restenosis: Angioplasty With Drug-Coated Balloon or Repeat Stenting With DES – Which Treatment for Which Patient?

Presenter: Fernando Alfonso

October 15, 2020

News Conference News TCT 2020

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Michael O'Riordan

October 14, 2020

Presentation TCT 2020

TCT 694: Recurrent Carotid Artery In-Stent Restenosis - A Challenging Clinical Scenario

Presenter: Priya Kothapalli

October 14, 2020

Presentation TCT 2020

TCT 550: Combined Use of Off-Label Intravascular Lithotripsy and Brachytherapy for the Treatment of Recurrent Intracoronary Stent Restenosis

Presenter: Ilias Nikolakopoulos

October 14, 2020

Presentation TCT 2020

TCT 592: Recurrent In-Stent Restenosis - Exhausted Treatment Options?

Presenter: Mohammed Osheiba

October 14, 2020

Presentation TCT 2020

TCT 374: Adventitial Delivery of Nano-encapsulated Sirolimus (Nanolimus) to Reduce Restenosis in Injured Porcine Femoral Arteries

Presenter: Hui Ying Ang

October 14, 2020

Presentation TCT 2020

TCT 409: Mechanisms of Multi-layer In-stent Restenosis Assessed by Optical Coherence Tomography

Presenter: Musa Sharkawi

October 14, 2020

Presentation TCT 2020

TCT 406: Effect of a Prescriptive Optical Coherence Tomography Guided Strategy on Treatment of In-Stent Restenosis– Insights from the LightLab Initiative

Presenter: Kevin Croce

October 14, 2020

Presentation TCT 2020

TCT 240: Chronic Total Occlusion (CTO) Percutaneous Coronary Intervention (PCI) for In-Stent Restenosis: Insights From a Pooled Analysis of Four Multicenter Registries

Presenter: Evangelia Vemmou

October 14, 2020

Presentation TCT 2020

TCT 287: Treatment of Patients With Recurrent In-Stent Restenosis Who Failed Intravascular Brachytherapy

Presenter: Charan Yerasi

October 14, 2020

Presentation TCT 2020

TCT 286: Long-Term Outcomes Following Drug-Eluting Balloon Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis: Multicenter Propensity Score-Matched Analysis (DEB-Dragon Registry)

Presenter: Wojciech Wanha

October 14, 2020

News Daily News

Large UK Study Explores Use of Excimer Laser Coronary Atherectomy

Todd Neale

September 25, 2020

In-Stent Restenosis Accounts for 10% of All PCIs, Contemporary National Analysis Shows

News Daily News

In-Stent Restenosis Accounts for 10% of All PCIs, National Analysis Shows

L.A. McKeown

September 24, 2020

News Daily News

Document Proposes Procedure Volumes to Attain Competency in High-risk PCI

Todd Neale

September 22, 2020

Advertisement

FDA Says Newer Paclitaxel Data Are ‘Comforting’ but Limited

Stable CAD With High-Risk Anatomy Warrants PCI or CABG, APPROACH Suggests

Efemoral Medical Announces Successful First-In-Human Use of The Efemoral™ Vascular Scaffold System

DISRUPT PAD III: Lithotripsy Shows Promise in Heavily Calcified PAD

EXAMINATION Surprise: Few Late Event Gaps Between DES and BMS in STEMI

Direct Temsirolimus Delivery Promising in BTK: TANGO Phase II Study

In-Stent-Restenosis: Angioplasty With Drug-Coated Balloon or Repeat Stenting With DES – Which Treatment for Which Patient?

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

TCT 694: Recurrent Carotid Artery In-Stent Restenosis - A Challenging Clinical Scenario

TCT 550: Combined Use of Off-Label Intravascular Lithotripsy and Brachytherapy for the Treatment of Recurrent Intracoronary Stent Restenosis

TCT 592: Recurrent In-Stent Restenosis - Exhausted Treatment Options?

TCT 374: Adventitial Delivery of Nano-encapsulated Sirolimus (Nanolimus) to Reduce Restenosis in Injured Porcine Femoral Arteries

TCT 409: Mechanisms of Multi-layer In-stent Restenosis Assessed by Optical Coherence Tomography

TCT 406: Effect of a Prescriptive Optical Coherence Tomography Guided Strategy on Treatment of In-Stent Restenosis– Insights from the LightLab Initiative

TCT 240: Chronic Total Occlusion (CTO) Percutaneous Coronary Intervention (PCI) for In-Stent Restenosis: Insights From a Pooled Analysis of Four Multicenter Registries

TCT 287: Treatment of Patients With Recurrent In-Stent Restenosis Who Failed Intravascular Brachytherapy

TCT 286: Long-Term Outcomes Following Drug-Eluting Balloon Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis: Multicenter Propensity Score-Matched Analysis (DEB-Dragon Registry)

Large UK Study Explores Use of Excimer Laser Coronary Atherectomy

In-Stent Restenosis Accounts for 10% of All PCIs, National Analysis Shows

Document Proposes Procedure Volumes to Attain Competency in High-risk PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content